Imunon IMNN
NASDAQ IMNN
$1.28 -0.04 (-3.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Imunon (IMNN) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Imunon's Return on Capital Employed [ROCE] was -247.39% in Q1 2026, up 485.36 percentage points from -732.75% a year earlier but down 3.79 percentage points from the prior quarter.

Analysis

Imunon (IMNN) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Imunon came in at -229.67%, down 56.24 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now declined for four consecutive years, with a five-year change of -170.33 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -173.43% in FY2024 (-91.14 pp), -82.29% in FY2023 (-31.40 pp), -50.89% in FY2022 (-8.03 pp) and -42.86% in FY2021 (+16.49 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -732.75% (Q1 2025) and -26.72% (Q2 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in 1 of the last four quarters, with an average year-over-year change of -162.59 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2026 (a gain of 485.36 percentage points); the worst was Q1 2025 (a drop of 579.74 percentage points).
  • Per Business Quant data, IMNN's Return on Capital Employed [ROCE] in the three quarters before Q1 2026 was -243.61% (Q4 2025), -309.91% (Q3 2025) and -638.81% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Imunon 5.97 Mn 5.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -247.39%
Dec 31, 2025 -243.61%
Sep 30, 2025 -309.91%
Jun 30, 2025 -638.81%
Mar 31, 2025 -732.75%
Jun 30, 2024 -287.07%
Mar 31, 2024 -153.01%
Dec 31, 2023 -132.31%
Sep 30, 2023 -102.89%
Jun 30, 2023 -82.83%
Mar 31, 2023 -75.91%
Dec 31, 2022 -59.03%
Sep 30, 2022 -43.12%
Jun 30, 2022 -38.61%
Mar 31, 2022 -34.32%
Dec 31, 2021 -30.02%
Sep 30, 2021 -27.17%
Jun 30, 2021 -26.72%
Mar 31, 2021 -39.31%
Dec 31, 2020 -60.32%
API Access

Imunon Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMNN&period=max&api_key=YOUR_API_KEY